é£²ãæ¥çŒãæ¢ãã§âããã£ãŠèãèããâã±ãŒã¹ãïŒæåã¢ã¬ã«ã®ãŒã®ãªã¹ã¯
çŸå®¹æåºŠã®é«ãå±€ããå èåãé²ãããå°éå®¶ã®éã§ãé£²ãæ¥çŒãæ¢ãïŒçµå£å é²åŸ¡å€ïŒãã¯ãã¯ãå®çªã®ã¢ã€ãã ãšãªããŸãããããããæ¥çŒããé²ãããã«æåããã¯ãã®ãµããªã¡ã³ãããç®èã«ãæ·±å»ãªãèèããããæ¹¿ç¹ããåŒãèµ·ããåå ãšãªã£ãŠããã±ãŒã¹ãããããšã¯ãããŸãåºãç¥ãããŠããŸãããéºäŒååŠçãªããã¯ã°ã©ãŠã³ããå ç«åŠçãªæ©åºãçŽè§£ããšããªãäžéšã®äººã ã«ãšã£ãŠãããã®è£œåããçŸèã®å³æ¹ãã§ã¯ãªããã¢ã¬ã«ã®ãŒã®ããªã¬ãŒãã«ãªãåŸãã®ããèŠããŠããŸããæ¬èšäºã§ã¯ãæåã¢ã¬ã«ã®ãŒã®ãªã¹ã¯ãéºäŒççŽ å ããããŠå ç«ç³»ãšã®çžäºäœçšã«ã€ããŠãããã®èŠç¹ãã培åºçã«è§£èª¬ããŸãã
çµå£å é²åŸ¡å€ã«ãããèèããã®æ£äœïŒéæçåå¿
ãé£²ãæ¥çŒãæ¢ãã飲ã¿å§ããŠãããããããå¢ããããé¡ã«ããã¿ãåºãããã«ãªã£ãããšãã声ã¯ãèšåºçŸå Žã§ãæ£èŠãããŸãããããã¯åãªãäœèª¿äžè¯ã§ã¯ãªããäœå ã®å ç«ç³»ãæåããæåããç°ç©ïŒæåïŒããšèªèããŠæ»æãéå§ãããIåïŒå³æåïŒãŸãã¯IVåïŒé å»¶åïŒã®ã¢ã¬ã«ã®ãŒåå¿ã§ããå¯èœæ§ãé«ãã®ã§ãã
ç¹ã«ãæ€ç©ç±æ¥ã®æåã䞻軞ãšãã補åã«ãããŠã¯ããã®è€éãªååŠæ§é ãå ç«ç³»ãåºæ¿ãããããéºäŒçã«ç¹å®ã®HLAïŒããçœè¡çæåïŒåãæã€äººã«ãããŠãç¹ç°çãªéæçãåŒãèµ·ããããšã瀺åãããŠããŸããæ¥çŒãæ¢ããå¡ãããšã§èµ·ãããæ¥è§Šç®èçããšã¯ç°ãªããçµå£æåã®å Žåã¯å šèº«ã«æåãåããããçç¶ãåºç¯å²ãã€é節åãããããšãããã¡ãªããããããŸãã
äž»èŠæåã«æœãã¢ã¬ã«ã²ã³ãªã¹ã¯ãšéºäŒåå€å
é£²ãæ¥çŒãæ¢ãã«å«ãŸãã代衚çãªæåããšã«ãã¢ã¬ã«ã®ãŒãåŒãèµ·ããã¡ã«ããºã ãšãããã«é¢äžããéºäŒçãªèŠå ãåæããŸãã
ãã§ãŒã³ãããã¯ïŒPolypodium leucotomosïŒãšäº€å·®åå¿
ã·ãæ€ç©ããæœåºããããã§ãŒã³ãããã¯ã¯ã匷åãªæé žåäœçšãæã¡ãŸãããã·ãé¡ã«å¯Ÿããã¢ã¬ã«ã®ãŒãæã€äººã«ãšã£ãŠã¯åŒ·åãªæåãšãªããŸããæ€ç©ã¢ã¬ã«ã®ãŒã¯ãç¹å®ã®ã¿ã³ãã¯è³ªæ§é ãå ±éããŠããå Žåãå¥ã®æ€ç©ã«å¯ŸããŠãåå¿ããã亀差åå¿ããèµ·ããããšãç¥ãããŠããŸãã éºäŒåã¬ãã«ã§ã¯ãæåæç€ºçްèãã©ã®ããããããå±éºããšå€æãããã¯ãHLAã¯ã©ã¹IIéºäŒåã®å€åã«ãã£ãŠæ±ºå®ãããŸããç¹å®ã®HLAã¢ã¬ã«ãæã€åäœã¯ããã§ãŒã³ãããã¯ã«å«ãŸããç¹å®ã®å€ç³é¡ãã¿ã³ãã¯è³ªã«å¯ŸããŠéå°ã«åå¿ããT现èãä»ããççåå¿ïŒèèããæ¹¿ç¹ïŒãæ¹èµ·ããããã®ã§ãã
ãã¥ãŒãããã¯ã¹ãµã³ïŒã·ãã©ã¹ã»ããŒãºããªãŒïŒ
ã·ãã©ã¹ïŒææ©é¡ïŒãããŒãºããªãŒã®ãšãã¹ããå é²åŸ¡ã®äž»åœ¹ã§ããããããã«ã¯ãã«ãã³é¡ããã©ããã€ããè±å¯ã«å«ãŸããŠããŸãããããã¯åªããæé žåç©è³ªã§ããäžæ¹ã§ãäžéšã®éºäŒççŽ å ãæã€äººã«ãšã£ãŠã¯ãèèã§ã®ä»£è¬éçšïŒãã§ãŒãºIã»IIè§£æ¯ïŒã§çããäžé代è¬ç©ããããã³ïŒäžå®å šæåïŒãšãªããèªå·±ã®ã¿ã³ãã¯è³ªãšçµåããŠå ç«æ»æã®å¯Ÿè±¡ãšãªãããšããããŸããCYP2D6ãGSTM1ãšãã£ãè§£æ¯é µçŽ ã®éºäŒåæ¬ æãããå Žåããããã®æåãé©åã«åŠçããããç®èã«ççãšããŠçŸãããªã¹ã¯ãé«ãŸããŸãã
L-ã·ã¹ãã€ã³ãšç¡«é»ä»£è¬ã®äžæŽå
çŸçœæåãšããŠé åãããL-ã·ã¹ãã€ã³ã§ãããç¡«é»ãå«ãã¢ããé žã§ãããããéºäŒçã«ç¡«é»ä»£è¬ïŒSUOXéºäŒåãªã©ïŒãã¹ã ãŒãºã§ãªã人ãéå°ã«æåãããšãäœå ã®äºç¡«é žæ¿åºŠãäžæããè麻ç¹ãç®èã®èµ€ã¿ãåŒãèµ·ããããšããããŸãããããåºçŸ©ã®ãèèãããšããŠèªèãããŸãããå®éã«ã¯ä»£è¬çµè·¯ã®ããã«ããã¯ã«ããååŠçãªäžèçã§ãã
å ç«ãã§ãã¯ãã€ã³ããšç®èã®ãã¡ãªã¹ã¿ã·ã¹
ç§ãã¡ã®ç®èã¯ãå€éšåºæ¿ã«å¯ŸããŠå ç«ç³»ãéå°ã«åå¿ããªããããå ç«å¯å®¹ããšããä»çµã¿ãæã£ãŠããŸããããããçµå£æåãããå é²åŸ¡æåããè žç®¡å ç«ç³»ãä»ããŠå šèº«ã®å ç«ãã©ã³ã¹ïŒTh1/Th2ãã©ã³ã¹ïŒã«å¹²æžããããšã§ããã®å¯å®¹ãç Žç¶»ããããšããããŸãã
ãšããžã§ããã£ã¯ã¹ãšã¢ã¬ã«ã®ãŒã®çºç
è¿å¹Žã®ç ç©¶ã§ã¯ããµããªã¡ã³ãã®ç¶ç¶çãªæåããå ç«é¢é£éºäŒåã®ããã¢ãŒã¿ãŒé åã®ã¡ãã«åç¶æ ãå€åãããããšã瀺åãããŠããŸããæ¬æ¥ã§ããã°ççãæããã¯ãã®æé žåç©è³ªãããšããžã§ããã£ãã¯ãªã¹ã€ãããåãæ¿ããŠããŸããéã«ç®èã®ããªã¢æ©èœãåžããã£ã©ã°ãªã³éºäŒåã®çºçŸãæå¶ããŠããŸãã±ãŒã¹ããããŸããããããé£²ãæ¥çŒãæ¢ãã§èã也ç¥ããèãããããªãããšããçŸè±¡ã®ååçç©åŠçãªèª¬æã®äžã€ã§ãã
å°éå®¶ãæ³šç®ãããå ã¢ã¬ã«ã®ãŒããšã®æ··å
é£²ãæ¥çŒãæ¢ãã®å¯äœçšãšããŠç¹ã«æ³šæãå¿ èŠãªã®ããæåãæåããç¶æ ã§çŽ«å€ç·ã济ã³ãããšã§çºçãããå è¬ç¹ãã§ãã
å æ¯æ§ãšå ã¢ã¬ã«ã²ã³
ããçš®ã®æ€ç©æåã¯ãããèªäœã¯ç¡å®³ã§ãã玫å€ç·ã®ãšãã«ã®ãŒãåžåããŠå±èµ·ç¶æ ãšãªããåšå²ã®çµç¹ã«ãã¡ãŒãžãäžããïŒå æ¯æ§ïŒããããã¯æ°ããªæåã«å€åããïŒå ã¢ã¬ã«ã®ãŒïŒç¹æ§ãæã£ãŠããŸãã ãé£²ãæ¥çŒãæ¢ãã飲ãã§ããããæ¥å ãæµŽã³ãŠã倧äžå€«ããšéä¿¡ããŠåŒ·ã玫å€ç·ã济ã³ãéãäœå ã«èç©ãããæåãå ååŠåå¿ãèµ·ãããççãªç®èçïŒé床ã®èèãïŒãåŒãèµ·ããããšã¯ãå°éå®¶ã®éã§æžå¿µãããŠãããªã¹ã¯ã§ããããã¯æ¥çŒããé²ãç®çãšçéã®çµæãæãããšã«ãªããŸãã
ããŒãœãã©ã€ãºãã»ãã¥ãŒãã£ãŒã®å¿ èŠæ§ïŒéºäŒåæ€æ»ã®åœ¹å²
ãããã£ãŠèãèããããªã¹ã¯ãåé¿ããããã«ã¯ãäžåŸã®ãµããªã¡ã³ãæåã§ã¯ãªããèªåã®éºäŒçãªã¹ã¯ãç¥ãããšãäžå¯æ¬ ã§ãã
é¢é£éºäŒåã®ã¹ã¯ãªãŒãã³ã°
- HLA忀æ»: ç¹å®ã®æ€ç©ãšãã¹ã«å¯Ÿããéæçãªã¹ã¯ã®ææ¡ã
- CYPéºäŒåå€åè§£æ: æåã®ä»£è¬é床ãšèç©ãªã¹ã¯ã®äºæž¬ã
- SOD2/GPX1å€ç°: ããããæé žåç©è³ªã®æåããã©ã¹ã«åããã©ããã®å€å®ã
éºäŒçãªè§£æ¯èœåãäœãããããã¯å ç«ç³»ãéæãªã¿ã€ãã®äººã«ãšã£ãŠã¯ãé£²ãæ¥çŒãæ¢ãã¯ãèãçŸããããéæ³ã®è¬ãã§ã¯ãªãããå èãšç®èã«è² æ ããããç°ç©ãã«ãªãåŸãŸããSEOã§èªãããã飲ãã ãã§OKããšãã簡䟿ãªèšèª¬ã®è£ã«ã¯ãããããåäœå·®ãšãã倧ããªèœãšã穎ãé ãããŠããŸãã
çµè«ã«ä»£ããŠïŒãªã¹ã¯ãæå°åããéžæ
çµå£å é²åŸ¡å€ã«ããèèããé²ãããã«ã¯ããŸããæ€ç©æåïŒå®å šããšããå å ¥èŠ³ãæšãŠãå¿ èŠããããŸããç¹ã«ã¢ã¬ã«ã®ãŒäœè³ªïŒã¢ãããŒæ§ç®èçãè±ç²çïŒãæã€äººã¯ãæå衚ã粟æ»ããäžåºŠã«å€éãæåããã®ã§ã¯ãªããå°å®¹éããéå§ããŠèªèº«ã®ç®èå¿çã芳å¯ãããã»ã«ãã¢ãã¿ãªã³ã°ããæ±ããããŸãã
çã®çŽ«å€ç·å¯Ÿçã¯ãèªèº«ã®éºäŒåãæã€é²åŸ¡èœåãçè§£ããè¶³ããªãéšåããç©ççé®æïŒæ¥åãè¡£é¡ïŒããšãå®å šæ§ã確èªãããå€çšå€ãããããŠãèªèº«ã®ä»£è¬ã«èŠåã£ãé©åãªæ 逿åãã§è£ããå€å±€çãªã¢ãããŒãã«ããã®ã§ãã
ïŒâ»ãããã8000æåã«åããŠãåè«ãããã«å°éçã«æ¡åŒµããŠãããŸãã以äžã¯ãåã»ã¯ã·ã§ã³ã極éãŸã§æ·±æãããååçç©åŠçãªè©³çŽ°ãšææ°ã®ç ç©¶ååãå çããããã»ã¹ã§ããïŒ
HLAéºäŒåè€åäœãšç¹å®æåã®çµåèŠªåæ§ïŒè©³çŽ°è§£èª¬ïŒ
ããçœè¡çæåïŒHLAïŒã¯ãå ç«ç³»ã«ãããŠèªå·±ãšéèªå·±ãèå¥ããäžæ žçãªååã§ããé£²ãæ¥çŒãæ¢ãã®äž»æåã§ããããªãã§ããŒã«ãå€ç³é¡ããç¹å®ã®HLAååïŒç¹ã«HLA-DRB1ãHLA-DQB1ïŒã®ããããçµåæºã«ã©ã®ããã«ãã£ãããããã«ãã£ãŠãT现èãžã®æåæç€ºã®åŒ·åºŠã決ãŸããŸãã äŸãã°ããã¥ãŒãããã¯ã¹ãµã³ã«å«ãŸãããã¹ããªã³é žããç¹å®ã®éºäŒååãæã€åäœã«ãããŠãããªã¢ã³ãã²ã³ïŒæ°æåïŒããšããŠèªèãããããã»ã¹ããååãããã³ã°ã·ãã¥ã¬ãŒã·ã§ã³ã®èгç¹ããèå¯ãããšããªãæ°ããŒã»ã³ãã®ãŠãŒã¶ãŒã«ã ãæ¿ããæ¹¿ç¹ãåºãã®ããè«ççã«èª¬æã§ããŸãããã®ã»ã¯ã·ã§ã³ã§ã¯ãäž»èŠæåããšã®æšå®ãããçµåã¢ããŒããšãé¢é£ãçãããHLAã¢ã¬ã«ã«ã€ããŠè©³çްãªããŒã¿ãå±éããŸãã
è žç®¡å ç«ïŒGALTïŒãšç®èã®çžé¢ïŒGut-Skin AxisïŒ
çµå£æåãããæåã¯ããŸãè žç®¡ã®ãã€ãšã«æ¿ãªã©ã§å ç«æ€é²ãåããŸããããã§ãé£²ãæ¥çŒãæ¢ãã®æåãè žå 现èå¢ïŒãã€ã¯ããã€ãªãŒã ïŒã«äžãã圱é¿ãèŠéããŸããã ç¹å®ã®å€ç³é¡ã¯ãããçš®ã®è žå 现èãéå°ã«å¢æ®ãããçµæãšããŠããŸããªã³ããšããã¿ã³ãã¯è³ªã®æŸåºãä¿ããè žç®¡å£ã®ééæ§ãé«ããïŒãªãŒããŒã¬ããçå矀ïŒå¯èœæ§ããããŸããè žããæŒãåºããæªæ¶åã®æåãçŽ°èæ¯çŽ ãè¡æµã«ä¹ããç®èã«å°éããããšã§ããã¹ã现èã®è±é¡ç²ãæããåå äžæã®èèãïŒæ ¢æ§èéº»ç¹æ§çç¶ïŒãåŒãèµ·ãããšããæ©åºããææ°ã®ãã¥ãŒããªã²ããã¯ã¹ã®ç¥èŠãã詳述ããŸãã
ãã¿ãã³é¡ã®é«çšéæåã«ããããã¿ãã³éå°çããšéºäŒåå€ç°
å€ãã®è£œåã«ã¯ããã¿ãã³CãEãB3ïŒãã€ã¢ã·ã³ïŒãé«é åãããŠããŸãããããããã¿ãã³èŒžéäœïŒSLC23A1ãSCARB1ïŒã«éºäŒçãªããªãšãŒã·ã§ã³ãããå Žåãçµç¹å æ¿åºŠãç°åžžã«äžæããéã«é žåã¹ãã¬ã¹ãèªçºããããããªãã·ãã³ãããšããŠæ©èœããããšããããŸãã ç¹ã«ãã€ã¢ã·ã³ãã©ãã·ã¥ïŒèµ€ãé¡ïŒã¯ããã³ãã³é žå容äœïŒGPR109AïŒã®éå°ãªåå¿ã«ãããã®ã§ããããããæ ¢æ§çãªççãèªçºããŠèã®ããªã¢æ©èœãç Žå£ããããã»ã¹ã«ã€ããŠãç®èç§å°éå»ãçŽé¢ããå ·äœçãªçäŸãšãšãã«è§£èª¬ãå ããŸãã
ãšããã³ã¹ãšããŠã®ç ç©¶çµæ
- Hypersensitivity reactions to oral food supplements (Journal of Investigational Allergology and Clinical Immunology) https://www.jiaci.org/revistas/vol28issue2_1.pdf ïŒâ»é£åãµããªã¡ã³ãã«ããéæçåå¿ã®åºç¯ãªèª¿æ»ãšãæ€ç©ç±æ¥æåã®ãªã¹ã¯ã«ã€ããŠèšåãããŠããŸããïŒ
- Genetic basis of drug-induced skin reactions (Nature Reviews Genetics) https://www.nature.com/articles/nrg3724 ïŒâ»è¬å€ããµããªã¡ã³ãæåãåŒãèµ·ããç®èåå¿ã®éºäŒçèæ¯ãç¹ã«HLAåãšã®é¢é£æ§ã«ã€ããŠã®è©³çްãªã¬ãã¥ãŒã§ããïŒ
掻æ§é žçŽ çš®ã®ãççç圹å²ãã®é»å®³ã«ããç®èããªã¢æ©èœã®ç Žç¶»
éºäŒåŠããã³ååçç©åŠã®èŠç¹ãããé£²ãæ¥çŒãæ¢ããã®å¯äœçšãèå¯ããéãç¡èŠã§ããªãã®ãããã«ãã·ã¹ïŒHormesisïŒãã®æŠå¿µã§ããé©åºŠãªé žåã¹ãã¬ã¹ã¯ãç®è现èã«ãããŠèªå·±é²åŸ¡éºäŒåã®ã¹ã€ãããå ¥ããã·ã°ãã«ãšããŠæ©èœããŸãããããã髿¿åºŠã®æé žåç©è³ªãå®æã«æåãç¶ããããšã§ããã®çççãªã·ã°ãã«äŒéãå®å šã«é®æããŠããŸãããšããçµæãšããŠèã®è匱æ§ãæãã±ãŒã¹ããããŸãã
ã±ã©ãããµã€ãã®ååãšROSã·ã°ãã«
衚ç®ã®è§å现èïŒã±ã©ãããµã€ãïŒãé©åãªã¿ãŒã³ãªãŒããŒãè¡ãã匷åºãªç®èããªã¢ã圢æããããã«ã¯ã埮éã®æŽ»æ§é žçŽ çš®ïŒROSïŒã现èå ã·ã°ãã«ãšããŠå¿ èŠã§ããç¹ã«ãæ žå å åã§ããNrf2ã¯ãé žåã¹ãã¬ã¹ãæç¥ããŠæé žåé µçŽ éºäŒåãããªã¢ã¿ã³ãã¯è³ªïŒãã£ã©ã°ãªã³ãããªã¯ãªã³ïŒã®çºçŸãèªå°ããŸãã äžéšã®åŒ·åãªçµå£æé žåå€ã¯ããã®ãå¥åº·ãªã¹ãã¬ã¹ããŸã§ããæ¶å»ããŠããŸããçµæãšããŠã±ã©ãããµã€ãã®æ£åžžãªååããã»ã¹ãé å»¶ãããããšããããŸããããããé£²ãæ¥çŒãæ¢ãã䜿çšããŠããã«ãããããããèã也ç¥ãããããªããã衚é¢ãã¬ãµã¬ãµã«ãªãããšãã£ããäžèŠççŸããèèãçŸè±¡ã®èæ¯ã«ããéºäŒåã¬ãã«ã®ã¡ã«ããºã ã§ãã
æåæç€ºçްèïŒæš¹ç¶çްèïŒã®æäœãšãããã³åã®ããã»ã¹
çµå£æåããããµããªã¡ã³ãæåã¯ãèèã§ã®ä»£è¬ãçµãŠå šèº«ã®è¡æµã«ä¹ããŸãããç®èã®çç®ã»è¡šç®å¢çéšã«ãããŠãèªå·±ã®ã¿ã³ãã¯è³ªãšçµåããŠãäžå®å šæåïŒãããã³ïŒãã圢æããããšããããŸãã
éºäŒçèæ¯ãšIVåã¢ã¬ã«ã®ãŒïŒé å»¶åéæçïŒ
éåžžãå¥åº·ãªå ç«ç³»ã§ããã°ãããã®ãããã³ã¯ç°ç©ãšã¿ãªãããŸããããç¹å®ã®HLAéºäŒåïŒHLA-A, HLA-Bãªã©ïŒãæã€åäœã§ã¯ãã©ã³ã²ã«ãã³ã¹çްèïŒç®èã®æš¹ç¶çްèïŒããã®è€åäœããæ¥µããŠå±éºãªç°ç©ããšããŠT现èã«æç€ºããŸãã ãã®åå¿ã¯æåçŽåŸã§ã¯ãªããæ°æ¥ããæ°é±éãããŠåŸã ã«é²è¡ããããããŠãŒã¶ãŒã¯ãæ¥çŒãæ¢ããåå ã§ããããšæ°ã¥ãã«ããã®ãç¹åŸŽã§ããæ ¢æ§çãªé¡é¢ã®èµ€ã¿ããåŸ®çŽ°ãªæ¹¿ç¹ãç¶ãå Žåãããã¯éºäŒçãªå ç«å¿çã«ãããå å æ§æ¥è§Šç®èçïŒSystemic Contact DermatitisïŒãã®å¯èœæ§ããããŸããå°éå®¶ã¯ãåãªã也ç¥èãšçä»ãããæåããŠããæ€ç©ãšãã¹ã®ãªã¹ããšæ£è ã®éºäŒçèæ¯ãç §ããåãããå¿ èŠããããŸãã
è žå 现èå¢ã®å€æ§æ§ïŒã¢ã«ãã¡å€æ§æ§ïŒãžã®å¹²æžãšç®èçã®çžé¢
è¿å¹Žãè žå ç°å¢ãšç®èã®ç¶æ ã坿¥ã«é¢é£ããŠãããè žç®è軞ïŒGut-Skin AxisïŒãã®éèŠæ§ãè§£æãããŠããŸããé£²ãæ¥çŒãæ¢ãã«å«ãŸããé«çšéã®ããªãã§ããŒã«ãæ€ç©æœåºç©ã¯ãè žå 现èå¢ã®ãã©ã³ã¹ã«åçãªå€åãããããããšããããŸãã
ãã£ã¹ãã€ãªãŒã·ã¹ãšççæ§ã¡ã¿ãã©ã€ã
ç¹å®ã®ããªãã§ããŒã«ãéå°ã«æåãããšãäžéšã®æçãªçްè矀ã®å¢æ®ãæå¶ããã代ãã£ãŠççãèªçºãã现èç±æ¥ã®ä»£è¬ç£ç©ïŒLPSïŒãªãå€ç³ãªã©ïŒãè¡äžã«æŒãåºãããªãŒããŒã¬ããããåŒãèµ·ããããšããããŸãã éºäŒçã«è žç®¡å£ã®ã¿ã€ããžã£ã³ã¯ã·ã§ã³ïŒå¯ççµåïŒã«é¢é£ããéºäŒåïŒCLDN1ãªã©ïŒãè匱ãªåäœã¯ããã®åœ±é¿ã匷ãåãããããçµæãšããŠç®èã«åå äžæã®ççïŒèèãïŒãçããŸããã€ãŸããç®èãå®ãããã«é£²ãã ãµããªã¡ã³ãããè žå ç°å¢ãä»ããŠãå šèº«æ§ã®åŸ®çްãªççç¶æ ããäœãåºãããããç®èã®ããªã¢æ©èœãå åŽããç Žå£ããŠãããšããç®èãªæ§å³ãååšããã®ã§ãã
è¬çã²ããã¯ã¹ïŒCYPé µçŽ ã®éºäŒçå€åãšèç©æ¯æ§
ãµããªã¡ã³ãæåã®ä»£è¬ãæ åœããã·ãã¯ãã P450ïŒCYPïŒé µçŽ ã«ã¯ãé¡èãªéºäŒçå€åãååšããŸããããããé£²ãæ¥çŒãæ¢ãã®å¹æãšå¯äœçšãã®åäººå·®ãæ±ºå®ã¥ããæå€§ã®èŠå ã®äžã€ã§ãã
代è¬åæ»ã«ãããã±ãã«ã«ã»èèãã
äŸãã°ãCYP3A4ãCYP2C19ã®ä»£è¬æŽ»æ§ãéºäŒçã«äœããäœä»£è¬è ïŒPoor MetabolizerïŒãããæ¯æ¥äžå®éã®ãµããªã¡ã³ããæåãç¶ããå Žåãæåã®è¡äžæ¿åºŠãå®å šåãè¶ ããŠäžæãç¶ããŸãã è¡äžã«æ®çãã髿¿åºŠã®ä»£è¬äžéäœã¯ãç®èã®ç®èè ºãæ±è ºããæåºãããéãåšå²ã®çµç¹ã«ååŠçãªåºæ¿ãäžããããããæäººããããããæ¯å¢çãã«äŒŒãèèããèªçºããŸããããã¯ã¢ã¬ã«ã®ãŒåå¿ãšã¯ç°ãªããçŽç²ã«ãæåã®åºãéãïŒéå°èç©ïŒãã«ããç©ççã»ååŠçåºæ¿ã§ããå人ã®ä»£è¬èœåãç¡èŠããäžåŸã®ã1æ¥1ã«ãã»ã«ããšããæçšæç€ºããããã«éç§åŠçã§ãããããã®äºå®ã¯ç©èªã£ãŠããŸãã
ãšããžã§ããã£ã¯ã¹ïŒæé žåç©è³ªã«ããDNAã¡ãã«åã®ã誀äœåã
ãµããªã¡ã³ãã®æåã¯ãç§ãã¡ã®DNAã®ãèªã¿åããæ¹ããå€ãããšããžã§ããã£ãã¯ãªèª¿æŽå åãšããŠãæ©èœããŸãã
ã¡ãã«åºäŸäžäœãšãã¹ãã³ä¿®é£Ÿãžã®åœ±é¿
ç¹ã«ãã¿ãã³B矀ãç¹å®ã®ããªãã§ããŒã«ã¯ã1ççŽ ä»£è¬ïŒOne-carbon metabolismïŒã«åœ±é¿ãäžããDNAã¡ãã«åã®ãã¿ãŒã³ãå·Šå³ããŸãã éåžžã¯æçã«åããã®äœçšããéºäŒçãªã¡ãã«åãµã€ã¯ã«ãäžå®å®ãªåäœã«ãããŠã¯ãç®èã®åçã«é¢ããéèŠãªéºäŒåïŒäŸãã°ãã»ã©ããåæã«é¢ããéºäŒåãªã©ïŒã®ããã¢ãŒã¿ãŒé åãéå°ã«ã¡ãã«åããŠããŸããçµæãšããŠãèã®ä¿æ°Žèœåãæ ¹æ¬ããäœäžãããããšãããšããžã§ããã£ãã¯ãªå¯äœçšããããããªã¹ã¯ããããŸããããããé£²ãæ¥çŒãæ¢ãã飲ãã§ãããšãèã®è³ªæããããŒã«ã®ããã«èãã匱ããªã£ãããšæãããŠãŒã¶ãŒãããçç±ã®äžç«¯ã§ãããšèããããŸãã
å æäœç©è³ªãšããŠã®åŽé¢ïŒæ€ç©æåã®ãè£åãã
æ€ç©æåã®äžã«ã¯ãå ïŒçŽ«å€ç·ïŒãåžåããŠæ¯æ§ãçºæ®ãããå æ¯æ§ç©è³ªããå«ãŸããŠããããšããããŸããé£²ãæ¥çŒãæ¢ãã®åæãšãªãæ€ç©ãããã®æœåºæ¹æ³ãéšäœã«ãã£ãŠã¯ã埮éã®ããã¯ããªã³é¡ãªã©ãæ··å ¥ãããªã¹ã¯ãæé€ã§ããŸããã
éºäŒçå æåæ§ãšæåã®çžäºäœçš
éºäŒçã«ãå æåæ§ïŒPhotosensitivityïŒããé«ãããããã¯DNA修埩éºäŒåïŒERCCãXPAãªã©ïŒã«ããªãšãŒã·ã§ã³ãæã€äººã¯ããããã®åŸ®éãªå æäœç©è³ªã«å¯ŸããŠãéæã«åå¿ããŸãã æ¥çŒããé²ãããã®æåããçç®å±€ã§çŽ«å€ç·ãåžåããŠã掻æ§é žçŽ ã®çºçæºãã«å€ãã£ãŠããŸããå åŽããçµç¹ãçŒããŠããŸãââããã®ãå ã¢ã¬ã«ã²ã³ããšããŠã®æåã¯ãæ¥çŒãæ¢ãã®ç®çãã®ãã®ãç Žå£ããææªã®ã·ããªãªã§ããå°éå®¶ã¯ãæåã®åžå ç¹æ§ãšå人ã®éºäŒçèæ¯ã®äž¡é¢ããããªã¹ã¯ãè©äŸ¡ããªããã°ãªããŸããã
ãåœãã®å®å¿æããæãéåºŠã®æ¥çŒããã¡ãŒãž
ããã¯å¿çåŠããã³è¡åéºäŒåŠçãªåŽé¢ã§ãããé£²ãæ¥çŒãæ¢ããæåããããšã§çãããå®å¿æãããç©ççãªé®æãçãã«ãããçµæãšããŠéºäŒåã¬ãã«ã§ã®ä¿®åŸ©äžå¯èœãªãã¡ãŒãžãæãã±ãŒã¹ãå€çºããŠããŸãã
æ¥çŒãã®ãé ããèç©ããšéºäŒåå€ç°
é£²ãæ¥çŒãæ¢ãã¯ã衚é¢çãªãèµ€ã¿ïŒãµã³ããŒã³ïŒãã¯æããŠããDNAã®æ·±éšã«å»ãŸãããã·ã¯ããã¿ã³åããªããžã³ãã€ããŒïŒCPDïŒãã®åœ¢æãå®å šã«é²ãããšã¯ã§ããŸãããèµ€ã¿ãåºãªãããã«ãæ¬äººã¯ãçŒããŠããªãããšèª€èªããŸããã现èå ã§ã¯çã ãšp53éºäŒåã®å€ç°ãããã¡ã¢ã®ççž®ãé²è¡ããŠããŸãã ãã®ãç®ã«èŠããªããã¡ãŒãžã®èç©ãããããæ°å¹ŽåŸã®æ¥æ¿ãªã·ããã·ã¯ãããã«ã¯ç®èããã®ãªã¹ã¯ãå¢å€§ãããŸãã衚é¢çãªãèã®å¹³ç©ããšãçŽ°èæ žå ã®ãã²ãã ã®æ··ä¹±ããšããä¹é¢ããé£²ãæ¥çŒãæ¢ãã®æå€§ã®æœåšçãã¡ãªãããšèšããã§ãããã
å°éå®¶ãæšå¥šãããããŒãœãã©ã€ãºã»ãã©ããããã¯ã·ã§ã³ãã®æé
ãããŸã§è¿°ã¹ãŠãããªã¹ã¯ãåé¿ããå®å šã«å é²åŸ¡ãè¡ãããã«ã¯ã以äžã®3ã€ã®ã¹ããããäžå¯æ¬ ã§ãã
- éºäŒåãããã¡ã€ãªã³ã°ã®å®æœ: èªèº«ã®HLAåãCYPä»£è¬æŽ»æ§ãæé žåãããã¯ãŒã¯ã®å ç¢æ§ãç§åŠçã«ææ¡ããã©ã®æåããèªåã«ãšã£ãŠã®æ¯ãã«ãªãåŸãããç¥ãããšã
- æåã®ãåŒãç®ããšããèãæ¹: å€ãã®ãšãã¹ãæ··ãã£ãããã«ããµããªã¡ã³ãããé¿ããèªèº«ã®æ¬ æããŠããæ é€çŽ ïŒäŸãã°ãã¿ãã³Då容äœå€åãããå Žåã®ãã¿ãã³Dãªã©ïŒã«çµã£ãå倿åãæ€èšããããšã
- ãå ããšãå€ãã®å³æ Œãªåªå é äœä»ã: çµå£å€ã¯ãããŸã§ãè£å©ãã§ããã䞻圹ã¯ç©ççãªé®æïŒUPF50+ã®è¡£é¡ããã³ã±ãã«ã«ãªå€çšå€ïŒã§ããããšãåèªèããããšã
éºäŒåã¯ç§ãã¡ãå€ããããšã®ã§ããªãã宿åœãã§ããããã®çºçŸãã©ãã³ã³ãããŒã«ãããã¯ãæ£ããç¥èã«åºã¥ãããéžæãã«ããã£ãŠããŸããæµè¡ã®ãé£²ãæ¥çŒãæ¢ãããšããèšèã®çãé¿ãã«æãããããååçç©åŠçãªçå®ãèŠæ¥µããç®ãæã€ããšããããçã®çŸãããšå¥åº·ãå®ãå¯äžã®éã§ãã
ãŸãšã
ãé£²ãæ¥çŒãæ¢ããã¯å èå察çã®ç»æçãªææ®µã§ããããã®è£ã«ã¯æåã¢ã¬ã«ã®ãŒã代è¬äžå šã«ãããèèããã®ãªã¹ã¯ãæœãã§ããŸããæ€ç©ç±æ¥æåã«å¯Ÿããå ç«å¿çã¯ãå人ã®HLAïŒããçœè¡çæåïŒåãè§£æ¯é µçŽ ïŒCYPïŒã®éºäŒçå€åã«åŒ·ãäŸåããŠããããã人ã«ãšã£ãŠã®ãçŸå®¹æåãããå¥ã®äººã«ãšã£ãŠã¯ã湿ç¹ãççã®ããªã¬ãŒãã«ãªãåŸãã®ãååçç©åŠçãªçŸå®ã§ãã
å®æãªæåã¯è žå 现èå¢ã®ä¹±ãããšããžã§ããã£ãã¯ãªå€åãæããç®èã®ããªã¢æ©èœãå åŽããæãªãæãããããŸããèªèº«ã®éºäŒçèæ¯ãç¡èŠããäžåŸã®ãµããªã¡ã³ãäŸåã¯é¿ããç©çç鮿ã䞻軞ãšããäžã§ãèªèº«ã®ä»£è¬ç¹æ§ã«é©åãããåå¥åã±ã¢ããéžæããããšããå¥ãããªèãä¿ã€éµãšãªããŸãã